Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4

FEBS Letters

Volumn 580, Issue 2, 2006, Pages 545-552

  Medveczky, Péter ^a   Antal, József ^a   Patthy, András ^a   Kékesi, Katalin ^a   Juhász, Gábor ^a   Szilágyi, László ^a   Gráf, László ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Autoimmune peptide; Central nervous system; Myelin degradation; Proteolysis; Serine protease; Trypsin

Indexed keywords

CALPAIN; CD4 ANTIGEN; CD8 ANTIGEN; MYELIN BASIC PROTEIN; TRYPSIN; TRYPSIN 1; TRYPSIN 4; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; DEMYELINATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HYDROLYSIS; IN VITRO STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; CALPAIN; HUMANS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; TRANSCRIPTION FACTORS; TRYPSIN; TRYPSINOGEN;

EID: 30644473886     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.12.067     Document Type: Article

References (24)

1. L. Steinman Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system Cell 85 1996 299 302
2. K.C. O'Connor, A. Bar-Or, and D.A. Hafler The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis J. Clin. Immunol. 21 2001 81 92
3. + T cells in multiple sclerosis J. Immunol. 172 2004 3893 3904
4. + cytotoxic T cell response to myelin basic protein in multiple sclerosis J. Immunol. 172 2004 5120 5127
5. J.D. Lutton, R. Winston, and T.C. Rodman Multiple sclerosis: etiological mechanisms and future directions Exp. Biol. Med. (Maywood) 229 2004 12 20
6. A. Prat, and J. Antel Pathogenesis of multiple sclerosis Curr. Opin. Neurol. 18 2005 225 230
7. D. Leppert, J. Ford, G. Stabler, C. Grygar, C. Lienert, S. Huber, K.M. Miller, S.L. Hauser, and L. Kappos Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis Brain 121 Pt 12 1998 2327 2334
8. D.C. Shields, K.E. Schaecher, T.C. Saido, and N.L. Banik A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain Proc. Natl. Acad. Sci. USA 96 1999 11486 11491
9. I.A. Scariscbrick, P.J. Isackson, B. Ciric, A.J. Windebank, and M. Rodriguez MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system J. Comp. Neurol. 431 2001 347 361
10. D. Gveric, R. Hanemaaijer, J. Newcombe, N.A. van Lent, C.F. Sier, and M.L. Cuzner Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage Brain 124 Pt 10 2001 1978 1988
11. P. Medveczky, E. Siklódi, J. Tóth, A. Patthy, K. Gallatz, P. Németh, M. Palkovits, L. Gráf, and L. Szilágyi Trypsinogen 4 with a 28 amino acid leader peptide on its N-terminus is the predominant form of the enzyme in human brain FEBS J. 272 2005 (s1)
12. J.C. Roach, K. Wang, L. Gan, and L. Hood The molecular evolution of the vertebrate trypsinogens J. Mol. Evol. 45 1997 640 652
13. G. Katona, G.I. Berglund, J. Hajdú, L. Gráf, and L. Szilágyi Crystal structure reveals basis for the inhibitor resistance of human brain trypsin J. Mol. Biol. 315 2002 1209 1218
14. R. Szmola, Z. Kukor, and M. Sahin-Tóth Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors J. Biol. Chem. 278 2003 48580 48589
15. U. Wiegand, S. Corbach, A. Minn, J. Kang, and B. Müller-Hill Cloning of the cDNA encoding human brain trypsinogen and characterization of its product Gene 136 1993 167 175
16. J.A. Maatta, E.T. Coffey, J.A. Hermonen, A.A. Salmi, and A.E. Hinkanen Detection of myelin basic protein isoforms by organic concentration Biochem. Biophys. Res. Commun. 283 1997 498 502
17. P. Riccio, A. Bobba, E. Romito, M. Minetola, and E. Quagliariello A new detergent to purify CNS myelin basic protein isoforms in lipid-bound form Neuroreport 5 6 1994 689 692
18. L. Szilágyi, E. Kénesi, G. Katona, G. Kaslik, G. Juhász, and L. Gráf Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis J. Biol. Chem. 276 2001 24574 24580
19. D.R. Beniac, M.D. Luckevich, G.J. Czarnota, T.A. Tompkins, R.A. Ridsdale, F.P. Ottensmeyer, M.A. Moscarello, and G. Harauz Three-dimensional structure of myelin basic protein. I. Reconstitution via angular reconstitution of randomly oriented single particles J. Biol. Chem. 272 1997 4261 4268
20. R.A. Ridsdale, D.R. Beniac, T.A. Tompkins, M.A. Moscarello, and G. Harauz Three-dimensional structure of myelin basic protein. II. Molecular modeling and considerations of predicted structures in multiple sclerosis J. Biol. Chem. 272 1997 4269 4275
21. K.A. Ericson, D.M. Payne, P.A. Martino, A.J. Rossomando, J. Shabanowitz, M.J. Weber, D.F. Hunt, and T.W. Sturgill Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase J. Biol. Chem. 265 1990 19728 19735
22. J.K. Kim, F.G. Mastronardi, D.D. Wood, D.M. Lubman, R. Zand, and M.A. Moscorello Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis Mol. Cell. Proteomics 2 2003 453 462
23. A. Minn, M. Schubert, W.F. Neiss, and B. Müller-Hill Enhanced GFAP expression in astrocytes of transgenic mice expressing the human brain-specific trypsinogen IV Glia 22 1998 338 347
24. G.S. Cottrell, S. Amadesi, E.F. Grady, and N.W. Bunnett Trypsin IV, a novel agonist of protease-activated receptors 2 and 4 J. Biol. Chem. 279 2004 13532 13539